Medical Research and Evaluation Facility (MREF) and studies supporting the medical chemical defense program: Development of procedures to enhance atropine antisera production in rabbits. Final report, July 1992-July 1994
The purpose of this study was to improve the production of rabbit anti-atropine antisera for future analytical studies. There were two phases to this project: evaluation of methods to enhance atropine antisera titers, and antisera production and characterization. Anti-atropine antisera were prepared using a high-density conjugate. The radioimmunoassay performance characteristics were similar for both the Battelle and Walter Reed Army Institute of Research antisera. However, a lower detection limit and a more dynamic response range were obtained with the Battelle antisera. Minor changes were made in the atropine radioimmunoassay to improve its reliability. There were approximately 250 mL of atropine antisera collected during this project, providing a useful antisera supply adequate for 250,000 tests.
- Research Organization:
- Battelle Columbus Labs., OH (United States)
- OSTI ID:
- 200169
- Report Number(s):
- AD-A-299786/4/XAB; CNN: Contract DAMD17-89-C-9050; TRN: 60511553
- Resource Relation:
- Other Information: PBD: Jul 1994
- Country of Publication:
- United States
- Language:
- English
Similar Records
Medical Research and Evaluation Facility (MREF) and studies supporting the medical chemical defense program. Determination of the minimum effective pyridostigmine pretreatment dose in monkeys challenged with 5 x LD50 Soman and treated with atropine/2-PAM. Final report, 22 October 1992-31 August 1993
Anti-idiotypic antisera in man. I. Production and immunochemical characterization of anti-idiotypic antisera to human antitetanus antibodies. [/sup 125/I tracer technique, rabbits]